Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Kaylee Nichols, PharmD Candidate 2022
Advertisement
Articles by Kaylee Nichols, PharmD Candidate 2022
Advertisement
Latest Updated Articles
Overview of Nurtec ODT for Prevention of Episodic MigrainePublished: January 4th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
4
Disparities in Continuous Glucose Monitor Prescriptions by Language Preference Among Adults With Type 2 Diabetes
5
